Axsome Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,087.80
2,617.80
48,036.30
36,618.50
34,021.10
13,968.70
Other Current Assets
9.50
125.90
996.60
1,380.60
1,278.40
1,246.40
Total Current Assets
2,097.40
2,743.80
49,032.90
37,999.10
35,299.50
15,215.10
Net Property, Plant & Equipment
-
-
16.70
100.70
68.10
51.80
Long-Term Note Receivable
5.10
-
-
-
-
-
Other Assets
-
42.60
26.60
112.80
188.00
112.30
Total Assets
2,102.50
2,786.40
49,076.20
38,212.60
35,555.60
15,379.30
ST Debt & Current Portion LT Debt
3,825.70
41.50
-
269.20
3,269.30
Accounts Payable
159.30
758.20
-
-
3,435.50
Other Current Liabilities
140.20
173.00
2,631.90
6,901.60
5,470.50
Total Current Liabilities
4,125.20
972.60
2,631.90
7,170.70
12,175.30
Long-Term Debt
-
4,937.80
-
9,470.40
6,663.00
Other Liabilities
-
78.50
-
-
-
Total Liabilities
4,125.20
5,989.00
2,631.90
16,641.20
18,838.30
Common Equity (Total)
2,022.70
3,202.60
46,444.30
21,571.50
16,717.20
Total Shareholders' Equity
2,022.70
3,202.60
46,444.30
21,571.50
16,717.20
Total Equity
2,022.70
3,202.60
46,444.30
21,571.50
16,717.20
Liabilities & Shareholders' Equity
2,102.50
2,786.40
49,076.20
38,212.60
35,555.60
About Axsome Therapeutics
View Profile
